DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

159.66 0.47 (0.30%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $159.66 0.30%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $159.37
Previous Close $159.19
Daily Range $159.00 - $160.30
52-Week Range $106.00 - $160.30
Market Cap $53.6B
P/E Ratio 103.37
Dividend (Yield) $0.00 (0.0%)
Volume 1,908,808
Average Daily Volume 2,071,820
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

Top Pharmaceutical Stocks to Buy for 2015

Three fast-growing pharmaceutical stocks that investors may want to consider owning in 2015.

New Guru Jana Partners' Newest Stock Buys

A Look At Actavis

Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog

Why Valeant Pharmaceuticals (VRX) Isn't Done Growing Earnings Yet - Tale of the Tape

UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formular

UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formulary Concerns Are Noise

Valeant CEO On Allegations Against The Company And Future M&A Deals

New Lifetime High Today: Valeant Pharmaceuticals International (VRX)

Valeant Pharmaceuticals, A Bet The Jockey Story With Upside

Analysts Make Bullish Ratings in Response to Valeant's Increased 2015 Guidance

Valeant Up on Better-than-Expected 2015 Outlook, Eyes Deals - Analyst Blog

Valeant Up on Better-than-Expected 2015 Outlook, Eyes Deals - Analyst Blog

See More VRX News...

VRX's Top Competitors

VRX $159.66 (0.30%)
Current stock: VRX
JNJ $102.20 (-1.50%)
Current stock: JNJ
NVS $96.87 (0.03%)
Current stock: NVS
RHHBY $35.35 (1.83%)
Current stock: RHHBY